Tyra Biosciences Inc (TYRA)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Todd J. Harris
Employees:
20
2656 STATE STREET, CARLSBAD, CA 92008
(619) 728-4760

Tyra Biosciences, Inc. focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer.

Data derived from most recent annual or quarterly report
Market Cap 280.868 Million Shares Outstanding41.61 Million Avg 30-day Volume 81.213 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.72
Price to Revenue0.0 Debt to Equity0.0 EBITDA-53.606 Million
Price to Book Value1.3787 Operating Margin0.0 Enterprise Value105.944 Million
Current Ratio48.729 EPS Growth0 Quick Ratio47.953
1 Yr BETA 1.4104 52-week High/Low 27.17 / 4.93 Profit Margin0.0
Operating Cash Flow Growth-174.4419 Altman Z-Score26.9911 Free Cash Flow to Firm 0

Are you looking for this stock instead?

View SEC Filings from TYRA instead.

View recent insider trading info

Funds Holding TYRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TYRA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PATEL PIYUSH R. CHIEF DEVELOPMENT OFFICER

  • Officer
82,236 2022-10-12 3

VAN DEN BOOM ESTHER CHIEF FINANCIAL OFFICER

  • Officer
240,542 2022-09-15 2

TADA HIROOMI CHIEF MEDICAL OFFICER

  • Officer
81,237 2022-09-15 2

HUDKINS ROBERT L. CHIEF TECHNOLOGY OFFICER

  • Officer
273,576 2022-09-15 2

HARRIS TODD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,969,468 2022-09-06 1

SWANSON RONALD V. CHIEF SCIENTIFIC OFFICER

  • Officer
378,254 2022-09-06 1

BENSEN DANIEL CHIEF OPERATING OFFICER

  • Officer
354,532 2022-09-06 1

MORE ROBERT J

  • Director
14,500 2022-06-13 1

KAPLAN GILLA

  • Director
14,500 2022-06-13 1

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

RA CAPITAL NEXUS FUND, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
14,500 2022-06-13 1

KJELLSON NINA S

  • Director
14,500 2022-06-13 1

CHEN ISAN

  • Director
14,500 2022-06-13 1

SIMSON JAKE

  • Director
14,500 2022-06-13 1

SUBRAMONY SIDDARTH

  • Director
  • 10% Owner
14,500 2022-06-13 1

VERJEE REHAN

  • Director
14,500 2022-06-13 1

FAWAZ ALI D. GENERAL COUNSEL AND SECRETARY

  • Officer
0 2022-05-16 2

HEALY JOHN STEPHEN GENERAL COUNSEL AND SECRETARY

  • Officer
0 2022-03-01 1

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

  • 10% Owner
6,448,359 2021-12-17 1

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

MVA INVESTORS, LLC

DAVIS AARON I.

  • 10% Owner
6,611,454 2021-09-17 1

ALTA PARTNERS NEXTGEN FUND II MANAGEMENT, LLC

ALTA PARTNERS NEXTGEN FUND II, L.P.

HUDSON PETER A

JANNEY DANIEL

  • 10% Owner
4,080,296 2021-09-17 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
1,827,364 2021-09-17 0

CANAAN XI L.P.

CANAAN PARTNERS XI LLC

CANAAN 2020+ CO-INVESTMENT L.P. SERIES 7

CANAAN PARTNERS 2020+ CO-INVESTMENT LLC

  • 10% Owner
4,409,991 2021-09-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PATEL PIYUSH R. - Officer CHIEF DEVELOPMENT OFFICER

2022-10-14 18:00:45 -0400 2022-10-12 G 56,276 d 82,236 direct -0.3096 8.0495 8.0495 6 -0.3096 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TYRA BIOSCIENCES INC TYRA 2022-11-25 22:15:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 21:45:04 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 21:15:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 20:45:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 20:15:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 19:45:04 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 19:15:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 18:45:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 18:15:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 17:45:04 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 17:15:03 UTC -5.3394 9.1594 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 16:45:04 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 16:15:03 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 15:45:03 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 15:15:03 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 14:45:04 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 14:15:04 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 13:45:03 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 13:15:03 UTC -5.2294 9.0494 10000
TYRA BIOSCIENCES INC TYRA 2022-11-25 12:45:03 UTC -5.2294 9.0494 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TYRA -708.0 shares, $-6223.32 2022-09-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments